Please login to the form below

Not currently logged in
Email:
Password:

merger

This page shows the latest merger news and features for those working in and with pharma, biotech and healthcare.

Pfizer names next CEO as Read retires

Pfizer names next CEO as Read retires

Another tax-inversion based (reverse) merger with Allergan was then agreed in 2015, only for the two companies to call it off after then-US President closed the tax loophole.

Latest news

More from news
Approximately 85 fully matching, plus 438 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 73 fully matching, plus 39 partially matching documents found.

Latest appointments

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    With expertise in corporate partnering, mergers and acquisitions, pipeline and product portfolio development, legal and IP strategy, Magovcevic-Liebisch has worked in several management roles including executive vice president and chief

  • IRX Therapeutics appoints Luba Greenwood to its board IRX Therapeutics appoints Luba Greenwood to its board

    Her career has spanned leadership roles in venture investing, business development, mergers and acquisitions, law, consulting and operations. ... Prior to that, she served as senior mergers and acquisitions counsel at Pfizer.

  • Reig Jofre boosts Forté Pharma’s senior team Reig Jofre boosts Forté Pharma’s senior team

    Ignasi Biosca, chief executive officer, Reig Jofre, said: “We had been working for some time on Forté Pharma's development plan after the merger with Natraceutical, and I am convinced that

  • Reig Jofre appoints Alejandro Reig as vice president Reig Jofre appoints Alejandro Reig as vice president

    He most recently took the director position at Reig Jofre after its merger with Natraceutical in December 2015.

  • Apeiron bolsters management board Apeiron bolsters management board

    With more than 25 years’experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently

More from appointments
Approximately 0 fully matching, plus 49 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 34 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics